Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Moderna Stock Surged Today


Shares of Moderna (NASDAQ: MRNA) rocketed higher on Monday, following bullish analyst commentary and news that the biotech company would be added to a popular stock market index.

As of 2:05 p.m. EDT, Moderna's stock was up more than 20%.

Moderna's experimental COVID-19 vaccine could produce annual sales of more than $5 billion, should it prove both safe and effective. So says Jefferies analyst Michael Yee, who began coverage of Moderna's stock with a buy rating and a $90 target price. 

Continue reading


Source Fool.com

Like: 0
Share

Comments